TY  - JOUR
AU  - Jecmenica Lukic, Milica
AU  - Respondek, Gesine
AU  - Kurz, Carolin
AU  - Compta, Yaroslau
AU  - Gelpi, Ellen
AU  - Ferguson, Leslie W
AU  - Rajput, Alex
AU  - Troakes, Claire
AU  - van Swieten, John C
AU  - Giese, Armin
AU  - Roeber, Sigrun
AU  - Herms, Jochen
AU  - Arzberger, Thomas
AU  - Höglinger, Günter
AU  - Giese, Armin
AU  - Troakes, Claire
AU  - Gelpi, Ellen
AU  - Respondek, Gesine
AU  - Höglinger, Günter U
AU  - van Swieten, John
AU  - Arzberger, Thomas
AU  - Compta, Yaroslau
AU  - Molina-Porcel, L.
AU  - Aldecoa, I.
AU  - Tolosa, E.
AU  - Martí, M. J.
AU  - Valldeoriola, F.
AU  - Pagonabarraga, J.
AU  - Calopa, M.
AU  - Bayès, A.
AU  - Hernandez, I.
AU  - Aguilar, M.
AU  - Genis, D.
TI  - Long-duration progressive supranuclear palsy: clinical course and pathological underpinnings.
JO  - Annals of neurology
VL  - 92
IS  - 4
SN  - 0364-5134
CY  - Hoboken, NJ
PB  - Wiley-Blackwell
M1  - DZNE-2022-01385
SP  - 637-649
PY  - 2022
AB  - To identify the clinical characteristics of the subgroup of benign progressive supranuclear palsy with particularly long disease duration; to define neuropathological determinants underlying variability in disease duration in progressive supranuclear palsy.Clinical and pathological features were compared among 186 autopsy-confirmed cases with progressive supranuclear palsy with ≥10 years and shorter survival times.45 cases (24.2
KW  - Astrocytes: metabolism
KW  - Autopsy
KW  - Disease Progression
KW  - Humans
KW  - Neurons: metabolism
KW  - Supranuclear Palsy, Progressive: pathology
KW  - tau Proteins: metabolism
LB  - PUB:(DE-HGF)16
C6  - pmid:35872640
DO  - DOI:10.1002/ana.26455
UR  - https://pub.dzne.de/record/164981
ER  -